Terms: = Pancreatic cancer AND HMGA2, HMGI-C, 8091, ENSG00000149948, LIPO, HMGIC, BABL AND Prognosis
13 results:
1. A necroptosis related prognostic model of pancreatic cancer based on single cell sequencing analysis and transcriptome analysis.
Chen L; Zhang X; Zhang Q; Zhang T; Xie J; Wei W; Wang Y; Yu H; Zhou H
Front Immunol; 2022; 13():1022420. PubMed ID: 36275722
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic Significance of
Saed L; Jeleń A; Mirowski M; Sałagacka-Kubiak A
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805937
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic significance of high mobility group A2 (hmga2) in pancreatic ductal adenocarcinoma: malignant functions of cytoplasmic hmga2 expression.
Gundlach JP; Hauser C; Schlegel FM; Willms A; Halske C; Röder C; Krüger S; Röcken C; Becker T; Kalthoff H; Trauzold A
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3313-3324. PubMed ID: 34302528
[TBL] [Abstract] [Full Text] [Related]
4. High mobility group AT-hook 2 promotes tumorigenicity of pancreatic cancer cells via upregulating ANLN.
Guo HH; Wang YZ; Zhang ZK; Li MZ; Tian XD; Yang YM
Exp Cell Res; 2020 Aug; 393(1):112088. PubMed ID: 32413362
[TBL] [Abstract] [Full Text] [Related]
5. OLR1 Promotes pancreatic cancer Metastasis via Increased c-Myc Expression and Transcription of hmga2.
Yang G; Xiong G; Feng M; Zhao F; Qiu J; Liu Y; Cao Z; Wang H; Yang J; You L; Zheng L; Zhang T; Zhao Y
Mol Cancer Res; 2020 May; 18(5):685-697. PubMed ID: 32019809
[TBL] [Abstract] [Full Text] [Related]
6. MiR-497 inhibits cell proliferation and invasion ability by targeting hmga2 in pancreatic ductal adenocarcinoma.
Zhou ZG; Xu C; Dong Z; Wang YP; Duan JY; Yan CQ
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):122-129. PubMed ID: 31957824
[TBL] [Abstract] [Full Text] [Related]
7. Hsa_circ_0006948 enhances cancer progression and epithelial-mesenchymal transition through the miR-490-3p/hmga2 axis in esophageal squamous cell carcinoma.
Pan Z; Lin J; Wu D; He X; Wang W; Hu X; Zhang L; Wang M
Aging (Albany NY); 2019 Dec; 11(24):11937-11954. PubMed ID: 31881015
[TBL] [Abstract] [Full Text] [Related]
8. Elevated high mobility group A2 expression in liver cancer predicts poor patient survival.
Zhao YC; Jiao Y; Li YQ; Fu Z; Yang ZY; He M
Rev Esp Enferm Dig; 2020 Jan; 112(1):27-33. PubMed ID: 31823639
[TBL] [Abstract] [Full Text] [Related]
9. Gene regulation by antitumor miR-130b-5p in pancreatic ductal adenocarcinoma: the clinical significance of oncogenic EPS8.
Fukuhisa H; Seki N; Idichi T; Kurahara H; Yamada Y; Toda H; Kita Y; Kawasaki Y; Tanoue K; Mataki Y; Maemura K; Natsugoe S
J Hum Genet; 2019 Jun; 64(6):521-534. PubMed ID: 30858505
[TBL] [Abstract] [Full Text] [Related]
10. Integrated analysis of tumor differentiation genes in pancreatic adenocarcinoma.
Xi T; Zhang G
PLoS One; 2018; 13(3):e0193427. PubMed ID: 29596435
[TBL] [Abstract] [Full Text] [Related]
11. SIRT6 Suppresses pancreatic cancer through Control of Lin28b.
Kugel S; Sebastián C; Fitamant J; Ross KN; Saha SK; Jain E; Gladden A; Arora KS; Kato Y; Rivera MN; Ramaswamy S; Sadreyev RI; Goren A; Deshpande V; Bardeesy N; Mostoslavsky R
Cell; 2016 Jun; 165(6):1401-1415. PubMed ID: 27180906
[TBL] [Abstract] [Full Text] [Related]
12. Identification of key regulators of pancreatic cancer progression through multidimensional systems-level analysis.
Rajamani D; Bhasin MK
Genome Med; 2016 May; 8(1):38. PubMed ID: 27137215
[TBL] [Abstract] [Full Text] [Related]
13. Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge.
Deng L; Yang SB; Xu FF; Zhang JH
J Exp Clin Cancer Res; 2015 Feb; 34(1):18. PubMed ID: 25884472
[TBL] [Abstract] [Full Text] [Related]
